CliffBio
small molecule

CARISOPRODOL AND ASPIRIN

ASPIRIN; CARISOPRODOL

Loss of exclusivity—loss of exclusivity
CompanyGenus Lifesciences Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameCARISOPRODOL AND ASPIRIN
Active ingredientASPIRIN; CARISOPRODOL
Strength325MG;200MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalApril 1996
Marketing statusDISCN

More from Genus Lifesciences Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CARISOPRODOL AND ASPIRIN patent cliff — loss of exclusivity — | CliffBio